Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125163) titled 'A cross-sectional study on the age distribution characteristics of serum BOD1 and related biomarkers and their influencing factors' on May 21.
Study Type: Interventional study
Study Design:
Cross-sectional
Primary Sponsor: Huai'an First People's Hospital
Condition:
Cognitive dysfunction
H0902
Intervention:
18-30 years age group:None
31-40 years age group:None
41-50 years age group:None
51-60 years age group:None
Recruitment Status: Not Recruiting
Phase: 1
Date of First Enrollment: 2026-05-21
Target Sample Size: 18-30 years age group:44;31-40 years age group:44;41-50 years age group:44;51-60 years age...